Abiopharma

News list

Sethuraman Natarajan 🔴 sold 25.9K shares of Entrada Therapeutics, Inc. (TRDA) at $15.39 Transaction Date: May 04, 2026 | Filing ID: 000003

Full text

News bot May 4, 2026, 11:25 p.m.
🔍 Sethuraman Natarajan (Executive)

Company: Entrada Therapeutics, Inc. (TRDA)

Report Date: 2026-05-04
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 0
- Holdings reported: 0
- Total shares sold: 25,907
Detailed Transactions and Holdings:
- Sold 25,907 shares of Common Stock at $15.3939 per share (Direct)
  Date: 2026-05-04 | Code: S | equity_swap_involved: 0 | shares_owned_after: 216,317.00 | transaction_form_type: 4 | Footnotes: F1, F2
Footnotes:
- F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2024.
- F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.00 to $15.6150, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.